NIH Director’s Blog: Tackling the Bottlenecks in the Drug Development Pipeline
Date: February 27, 2013
In his latest blog, NIH Director Francis Collins presents a few startling figures on the slow pace of drug discovery: the average length of time from target discovery to FDA approval of a new drug is 14 years, the failure rate exceeds 95 percent, and the cost per successful drug is more than $2 billion. Science could work to help science, however, as discoveries like biochips to determine drug-safety might someday reduce the number of necessary clinical trials and expedite the process. Find out more about efforts to ease the bottleneck on Collins’ blog.